Showing results (71-80 of 77) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
European Urology Oncology|November 14, 2018
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 TrialFern Anari, John O'Neill, Woonyoung Choi, et al.The Journal of Urology|April 21, 2021
Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration)Andrew B Katims, Rollin Say, Ithaar Derweesh, et al.World Journal of Urology|March 1, 2023
Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative GroupClara Cerrato, Devin Patel, Riccardo Autorino, et al.Minerva Urology and Nephrology|December 18, 2025
Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registryMargaret F Meagher, Clara Cerrato, Mimi V Nguyen, et al.Journal of Endourology|January 12, 2022
Robotic vs Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.The Lancet. Oncology|June 28, 2024
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 studyMohamad E Allaf, Se-Eun Kim, Viraj Master, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2017
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017Veda N Giri, Karen E Knudsen, William K Kelly, et al.Pageof 8